An uncommon t(9;11)(p24;q22) with monoallelic loss of ATM and KMT2A genes in a child with myelodysplastic syndrome/acute myeloid leukemia who evolved from Fanconi anemia

Molecular Cytogenetics
Viviane Lamim LovatelT de Souza Fernandez

Abstract

Myelodysplastic syndrome (MDS) is rare in the pediatric age group and it may be associated with inheritable bone marrow failure (BMF) such as Fanconi anemia (FA). FA is a rare multi-system genetic disorder, characterized by congenital malformations and progressive BMF. Patients with FA usually present chromosomal aberrations when evolving to MDS or acute myeloid leukemia (AML). Thus, the cytogenetic studies in the bone marrow (BM) of these patients have an important role in the therapeutic decision, mainly in the indication for hematopoietic stem cell transplantation (HSCT). The most frequent chromosomal alterations in the BM of FA patients are gains of the chromosomal regions 1q and 3q, and partial or complete loss of chromosome 7. However, the significance and the predictive value of such clonal alterations, with respect to malignant progress, are not fully understood and data from molecular cytogenetic studies are very limited. A five-year-old boy presented recurrent infections and persistent anemia. The BM biopsy revealed hypocellularity. G-banding was performed on BM cells and showed a normal karyotype. The physical examination showed to be characteristic of FA, being the diagnosis confirmed by DEB test. Five years later, ...Continue Reading

References

May 18, 2000·Journal of the National Cancer Institute·K K Khanna
Jun 28, 2002·Cell·Toshiyasu TaniguchiAlan D D'Andrea
Oct 13, 2006·Nature Reviews. Cancer·Stephan Lobitz, Eunike Velleuer
Jan 9, 2008·Seminars in Hematology·Charlotte M Niemeyer, Irith Baumann
Jun 11, 2009·Mutation Research·Lars U W Müller, David A Williams
May 11, 2011·British Journal of Haematology·Henrik Hasle, Charlotte M Niemeyer
Apr 21, 2012·Pediatric Blood & Cancer·Andrzej RochowskiBlanche P Alter
Jun 14, 2012·Anemia·Anneke B OostraJohan P de Winter
Nov 20, 2012·Nucleic Acids Research·Jean-Loup HuretPhilippe Dessen
Jun 2, 2016·International Journal of Molecular Sciences·Sarah A Bannon, Courtney D DiNardo
Feb 18, 2017·Journal of Pediatric Hematology/oncology·Maria L R BorgesTerezinha D J Marques-Salles
Feb 28, 2017·British Journal of Haematology·Ana C XavierLuciano J Costa
May 6, 2017·British Journal of Haematology·Carlo Dufour
Jul 14, 2017·Leukemia·C MeyerR Marschalek
Dec 5, 2017·Trends in Cancer·Manoj NepalPeiwen Fei

❮ Previous
Next ❯

Methods Mentioned

BETA
MDS
chromosomal aberrations

Related Concepts

Related Feeds

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.